Asahi Kasei in $1.3bn bid to access US pharma market
Asahi Kasei has a bid accepted for oral dose specialist, Veloxis, with one eye on gaining a position in the US market.
Archives for November 28, 2019
Celltrion gets EMA nod for subcutaneous infliximab biosimilar
Celltrion receives EMA marketing authorisation for Remsima SC, the first subcutaneously-administered option for delivery of infliximab, a treatment for rheumatoid arthritis.
Thermo Fisher expands site, boosts biologics processing offering
Thermo Fisher Scientific doubles the capacity of its gene therapy and viral vector processing facility in Alachua, Florida, to provide scalability to customers.
Recro spins out Baudax to boost CDMO focus
Recro Pharma announces the separation of its acute care business to launch Baudax Bio as a developer of products, including non-opioid analgesics, to concentrate on its CDMO business.